(Date:11/25/2009)..., , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cyto...ldt, PhD to its Board of Directors. Dr. Moldt will...ative on the Company,s Board. The number of Board ...e are very pleased to welcome Peter Moldt to the b...ience and guidance as Cytochroma continues to make...
(Date:11/25/2009)..., , SAN DIEGO, Nov. 25 /PRNewswire-FirstCal...ounced today that Barry D. Quart, Pharm.D., presid...he Piper Jaffray 21st Annual Health Care Conferenc... Jaffray 21st Annual Health Care Conference,Date: .... Eastern Time,Location: The New York Palace Hote...
(Date:11/24/2009)... Ambassador to also Visit D... 24, 2009 -- , , ,Who: David Appia, French Ambassa... CEO of the Invest in France Agency, , , , ,What:...to discuss recent pro-business initiatives adopted...l and academic landscape for innovation and develo...
(Date:11/24/2009)..., , CALGARY and BLENHEIM, Ontario, Nov. 24 /...nnounced today it is acquiring the assets of Hylan...im, Ontario. The addition of Hyland Seeds will fur...ss as the company anticipates the introduction of ...erbicide Tolerant Trait Technology in corn in 2012...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3(Date:11/25/2009)...NCETON, N.J., Nov. 25 Ph...pharmaceutical company committed to discovering, d... viral infections, reported financial results for ...mber 30, 2009 Pharmasset held $58.4 million in cas..., Pipeline Update and 2009 Highlights ,, ...
(Date:11/25/2009)...EWATER, N.J., Nov. 25 The FDA gran...virine) tablets, a non-nucleoside reverse transcri...TI specifically indicated for use in treatment-exp...lure with HIV-1 strains resistant to an NNRTI and ...l approval is based on 48-week data from two Phase...
(Date:11/25/2009)...KING RIDGE, N.J., Nov. 25 Regado B...evelopment of antithrombotic aptamers with active ...EO and President, will be presenting at the Piper ...New York Palace Hotel in New York City. Dr. Mazzo...uesday, December 1 and will include an overview of...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Antibody targeting of glioblastoma shows promise in preclinical tests say Lombardi researchers 9441 1Antibody targeting of glioblastoma shows promise in preclinical tests say Lombardi researchers 9441 2Antibody targeting of glioblastoma shows promise in preclinical tests say Lombardi researchers 9441 3Global curbs on overfishing are beginning to work 9439 1Global curbs on overfishing are beginning to work 9439 2Opening a new window on daylight 9437 1Opening a new window on daylight 9437 2